Review of Cystic Fibrosis
- PMID: 30986316
- DOI: 10.3928/19382359-20190327-01
Review of Cystic Fibrosis
Abstract
Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial airway infection. This latter feature results in progressive bronchiectasis and ultimately respiratory failure, which is the leading cause of death in patients with CF. Other complications include sinusitis, diabetes mellitus, bowel obstruction, hepatobiliary disease, hyponatremic dehydration, and infertility. Diagnosis of CF is confirmed by demonstration of elevated sweat chloride. Most cases of CF are identified through newborn screening (NBS). There are also infants with positive NBS but inconclusive diagnostic testing; a small proportion of these infants may go on to develop CF. CF is a lifelong, life-limiting disease, but an organized care center network with multidisciplinary approach, quality improvement initiatives, and research has led to markedly increased survival and development of adult CF care programs. In the past few years, medications that directly target the underlying CF defect have been developed, which should result in even greater survival benefits. [Pediatr Ann. 2019;48(4):e154-e161.].
Copyright 2019, SLACK Incorporated.
Similar articles
-
Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.J Pediatr. 2017 Feb;181S:S45-S51.e1. doi: 10.1016/j.jpeds.2016.09.066. J Pediatr. 2017. PMID: 28129812
-
Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.Dev Period Med. 2015 Jan-Mar;19(1):16-24. Dev Period Med. 2015. PMID: 26003066
-
Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis.J Cyst Fibros. 2016 May;15(3):313-7. doi: 10.1016/j.jcf.2015.12.024. Epub 2016 Jan 27. J Cyst Fibros. 2016. PMID: 26826912
-
Cystic Fibrosis Diagnosis and Newborn Screening.Pediatr Clin North Am. 2016 Aug;63(4):599-615. doi: 10.1016/j.pcl.2016.04.004. Pediatr Clin North Am. 2016. PMID: 27469178 Review.
-
The diagnosis of cystic fibrosis.Presse Med. 2017 Jun;46(6 Pt 2):e97-e108. doi: 10.1016/j.lpm.2017.04.010. Epub 2017 May 31. Presse Med. 2017. PMID: 28576637 Review.
Cited by
-
An unusual case of cystic fibrosis with pancytopenia due to copper deficiency and blindness caused by vitamin A deficiency: A case-report.Respir Med Case Rep. 2022 Nov 7;40:101774. doi: 10.1016/j.rmcr.2022.101774. eCollection 2022. Respir Med Case Rep. 2022. PMID: 36386283 Free PMC article.
-
Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review).Mol Med Rep. 2020 Dec;22(6):4992-5002. doi: 10.3892/mmr.2020.11607. Epub 2020 Oct 16. Mol Med Rep. 2020. PMID: 33173976 Free PMC article. Review.
-
Role of Olive Bioactive Compounds in Respiratory Diseases.Antioxidants (Basel). 2023 May 23;12(6):1140. doi: 10.3390/antiox12061140. Antioxidants (Basel). 2023. PMID: 37371870 Free PMC article. Review.
-
Pulmonary non-tuberculous mycobacterial infections: current state and future management.Eur J Clin Microbiol Infect Dis. 2020 May;39(5):799-826. doi: 10.1007/s10096-019-03771-0. Epub 2019 Dec 18. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31853742 Free PMC article. Review.
-
The Need for Precision Therapies as Determined by Genetic Signature for Cystic Fibrosis.J Pers Med. 2021 Dec 12;11(12):1353. doi: 10.3390/jpm11121353. J Pers Med. 2021. PMID: 34945826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous